Agency
Department of Health Professions
 
Board
Board of Pharmacy
 
chapter
Regulations Governing the Practice of Pharmacy [18 VAC 110 ‑ 20]
Previous Comment     Next Comment     Back to List of Comments
6/5/24  12:24 am
Commenter: Anonymous

Kratom Linked to Liver Toxicity. Schedule I classification will address
 
Kratom's impact on liver function and potential for hepatotoxicity is a major concern, posing serious health risks. These risks highlight the need for stringent regulation. Schedule I classification will address these health risks and ensure safer use
 
 
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Kratom. [Updated 2020 Apr 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548231/

 

CommentID: 224768